Pro Medicus FY26 slides: 28% revenue growth, A$407M in new contracts


Pro Medicus (ASX:PME) unveiled record financial results for fiscal year 2026 in its presentation dated August 18, 2026, showcasing robust growth across all key metrics despite currency headwinds. The medical imaging software company reported underlying revenue growth of 28% in constant currency terms, with EBIT margins expanding to 74.9%.
Reported by 2 outlets — Investing.com · Company News. See all sources ↓
Pro Medicus (ASX:PME) unveiled record financial results for fiscal year 2026 in its presentation dated August 18, 2026, showcasing robust growth across all key metrics despite currency headwinds. The medical imaging software company reported underlying revenue growth of 28% in constant currency terms, with EBIT margins expanding to 74.9%. The market responded enthusiastically, with shares surging 13.02% to A$198.76, building on a 12.4% pre-market jump following the initial release. The Melbourne-based company, which provides enterprise imaging and radiology information systems through its Visage 7 platform, continues to demonstrate exceptional operating leverage and market penetration in North America, where it now serves more than half of the top 20 U.S.
Read the full report at Investing.com · Company News ↗
Why it matters
2 outlets are covering this world story — one to watch as reporting develops.
- What's the story?
- Pro Medicus (ASX:PME) unveiled record financial results for fiscal year 2026 in its presentation dated August 18, 2026, showcasing robust growth across all key metrics despite currency headwinds. The medical imaging software company reported underlying revenue growth of 28% in constant currency terms, with EBIT margins expanding to 74.9%.
- How widely is it covered?
- 2 outlets, average source rating 5.0/10.
- When was it last updated?
- 8m ago.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
Pro Medicus FY26 slides: record growth, margins near 75%
Sources1TypeCoverageInvesting.com · Company News